Safety Issues concerning Anti-hCG Vaccines

Fathalla MF . Contraception and women's health. Br Med Bull 1993; 49(1): 245–51.

Aitken RJ , Paterson M , Thillai Koothan P. Contraceptive vaccines. Br Med Bull 1993; 49(1): 88–99.

Lincoln DW . Contraception for the year 2020. Br Med Bull 1993; 49(1): 222–36.

Jones WR . Contraception. Baillieres Clin Obstet Gynaecol 1992; 6(3): 629–40.

Dirnhofer S , Klieber R , De Leeuw R , Bidart JM , Merz WE , Wick G , Berger P. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin B: implications for the WHO birth control vaccine. FASEB J 1993; 7(14): 1381–5.

Roberge LF . Abortifacient Vaccine Technology: Overview, Hazards, and Christian Response. Linacre Quarterly 1995; August: 67–75.

Dirnhofer S , Wick G , Berger P. The suitability of human chorionic gonadotropin (hCG)-based birth-control vaccines. Immunol Today 1994; 15(10): 469–74.

Vaitukaitis JL , Ross GT , Reichert LE , Ward DN. Immunologic basis for within and between species cross reactivity of luteinizing hormone. Endocrinology 1972; 91: 1337–42.

Berger P , Klieber R , Panmoung W , Madersbacher S , Wolf H , Wick G. Monoclonal antibodies against the free subunits of human chorionic gonadotrophin. J Endocrinol 1990; 125: 301–9.

Dirnhofer S , Lechner O , Madersbacher S , Klieber R , de Leeuw R , Wick G , Beyer P. Free a subunit of human chorionic gonadotrophin: molecular basis of immunologically and biologically active domains. J Endocrinol 1994; 140: 145–54.

Schwarz S , Berger P , Nelboeck E. . J Recept Res 1988; 8: 437–53.

Berger P , Dirnhofer S , Klieber R , Frank R , Wick G in Follicle Stimulating Hormone: Regulation of Secretion and Molecular Mechanisms of Action. ( Hunzicker-Dunn , Schwartz NB , eds), Springer-Verlag. 1992; pp. 393–9.

Madersbacher S , Klieber R , Mann K , Marth C , Tabarelli M , Wick G , Berger P. Free a-subunit, free B-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem 1992; 38: 370–6.

Lei ZM , Toth P , Rao CV , Pridham D. Novel coexpression of human chorionic gonadotropin (hCG)/human leteinizing hormone receptors and their ligand hCG in human fallopian tubes. J Clin Endocrinol Metab 1993; 77: 863–72.

Xiong X , Buekens P , Wollast E. IUD use and the risk of ectopic pregnancy: A meta-analysis of case-control studies. Contraception 1995; 52: 23–34.

Richardson A. , Paul C. A national study to monitor the safety of IUD use. Contraception 1993; 47: 359–66.

Makkonen K. Problems in distribution of scientific knowledge: Intrauterine contraceptive devices and drug catalogs. Int J Health Serv 1993; 23: 173–83.

GynoPharma Inc. Patient information for an informed decision: ParaGard T380A Intrauterine Copper Contraceptive. The Corporation, Somerville, NJ. 1991.

ALZA Corporation. Progestasert: Intrauterine Progesterone Contraceptive System Patient Information. The Corporation, USA. 1989.